MyHealthChecked (MHC) Competitors GBX 12.50 +0.75 (+6.38%) As of 11:47 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsBuy This Stock MHC vs. POLX, IHC, AVO, RUA, SUN, BELL, DEMG, NIOX, SN, and MXCTShould you be buying MyHealthChecked stock or one of its competitors? The main competitors of MyHealthChecked include Polarean Imaging (POLX), Inspiration Healthcare Group (IHC), Advanced Oncotherapy (AVO), RUA Life Sciences (RUA), Surgical Innovations Group (SUN), Belluscura (BELL), Deltex Medical Group (DEMG), NIOX Group (NIOX), Smith & Nephew (SN), and MaxCyte (MXCT). These companies are all part of the "medical devices" industry. MyHealthChecked vs. Polarean Imaging Inspiration Healthcare Group Advanced Oncotherapy RUA Life Sciences Surgical Innovations Group Belluscura Deltex Medical Group NIOX Group Smith & Nephew MaxCyte Polarean Imaging (LON:POLX) and MyHealthChecked (LON:MHC) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, earnings, valuation, institutional ownership, dividends, media sentiment, analyst recommendations, risk and community ranking. Do institutionals & insiders believe in POLX or MHC? 12.1% of Polarean Imaging shares are held by institutional investors. Comparatively, 3.1% of MyHealthChecked shares are held by institutional investors. 39.3% of Polarean Imaging shares are held by company insiders. Comparatively, 53.6% of MyHealthChecked shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Is POLX or MHC more profitable? MyHealthChecked has a net margin of -11.06% compared to Polarean Imaging's net margin of -1,333.97%. MyHealthChecked's return on equity of -12.80% beat Polarean Imaging's return on equity.Company Net Margins Return on Equity Return on Assets Polarean Imaging-1,333.97% -86.11% -32.28% MyHealthChecked -11.06%-12.80%-8.18% Does the media favor POLX or MHC? In the previous week, Polarean Imaging had 1 more articles in the media than MyHealthChecked. MarketBeat recorded 1 mentions for Polarean Imaging and 0 mentions for MyHealthChecked. Polarean Imaging's average media sentiment score of 0.68 beat MyHealthChecked's score of 0.00 indicating that Polarean Imaging is being referred to more favorably in the media. Company Overall Sentiment Polarean Imaging Positive MyHealthChecked Neutral Which has higher earnings and valuation, POLX or MHC? MyHealthChecked has higher revenue and earnings than Polarean Imaging. MyHealthChecked is trading at a lower price-to-earnings ratio than Polarean Imaging, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPolarean Imaging£5.21M3.31-£69.44M-£3.89-0.30MyHealthChecked£9.43M0.69-£1.04M-£2.00-6.23 Does the MarketBeat Community prefer POLX or MHC? Polarean Imaging received 23 more outperform votes than MyHealthChecked when rated by MarketBeat users. CompanyUnderperformOutperformPolarean ImagingOutperform Votes2367.65% Underperform Votes1132.35% MyHealthCheckedN/AN/A Which has more volatility and risk, POLX or MHC? Polarean Imaging has a beta of 0.38, suggesting that its share price is 62% less volatile than the S&P 500. Comparatively, MyHealthChecked has a beta of 1.37, suggesting that its share price is 37% more volatile than the S&P 500. SummaryMyHealthChecked beats Polarean Imaging on 8 of the 14 factors compared between the two stocks. Get MyHealthChecked News Delivered to You Automatically Sign up to receive the latest news and ratings for MHC and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MHC vs. The Competition Export to ExcelMetricMyHealthCheckedMedical Devices IndustryMedical SectorLON ExchangeMarket Cap£6.50M£3.30B£5.33B£2.66BDividend YieldN/A2.44%5.21%5.05%P/E Ratio-6.2368.2226.85129.21Price / Sales0.69105.70388.74221,406.02Price / Cash1.7815.9938.2528.02Price / Book0.863.596.763.79Net Income-£1.04M£126.02M£3.23B£5.88B7 Day Performance3.09%4.40%1.71%0.63%1 Month Performance-3.85%7.62%11.16%22.11%1 Year Performance11.11%-3.76%17.17%120.87% MyHealthChecked Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MHCMyHealthCheckedN/AGBX 12.50+6.4%N/A+28.7%£6.50M£9.43M-6.2316Gap DownPOLXPolarean ImagingN/AGBX 1.21+0.8%N/A-68.3%£17.76M£5.21M-0.3128Gap DownHigh Trading VolumeIHCInspiration Healthcare GroupN/AGBX 17.95-0.3%N/A+13.8%£15.55M£42.87M-1.23224Gap DownHigh Trading VolumeAVOAdvanced OncotherapyN/AN/AN/AN/A£9.50MN/A-25.003,900Gap DownRUARUA Life SciencesN/AGBX 11.53-3.9%N/A+1.7%£7.15M£4.05M-2.6948Positive NewsSUNSurgical Innovations GroupN/AGBX 0.65flatN/A+40.0%£6.06M£12.54M-21.1180Gap UpBELLBelluscuraN/AGBX 1-12.3%N/A-94.2%£2.52M£2.87M-0.1124High Trading VolumeDEMGDeltex Medical GroupN/AN/AN/AN/A£187,000.00£1.76M-0.1537Gap UpHigh Trading VolumeNIOXNIOX Group1.9447 of 5 starsGBX 67.20-4.0%GBX 90+33.9%-10.3%£27.60B£3.53B2,773.2392News CoverageInsider TradeHigh Trading VolumeSNSmith & Nephew3.4243 of 5 starsGBX 1,056.50-0.9%GBX 7,840+642.1%+7.9%£11.58B£7.08B38.0418,452High Trading VolumeMXCTMaxCyteN/AGBX 164-1.2%N/A-55.4%£216.49M£57.52M-6.0180 Related Companies and Tools Related Companies Polarean Imaging Competitors Inspiration Healthcare Group Competitors Advanced Oncotherapy Competitors RUA Life Sciences Competitors Surgical Innovations Group Competitors Belluscura Competitors Deltex Medical Group Competitors NIOX Group Competitors Smith & Nephew Competitors MaxCyte Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:MHC) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredPrepare now for May 31 eventPrepare now for May 31 event Circle May 31 on your calendar This man grew up in a trailer in New Mexico. To...Stansberry Research | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MyHealthChecked PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share MyHealthChecked With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.